Fine structural design of 3βHSD1 inhibitors for prostate cancer therapy.
He D, Zhang L, Yu L, Zhang Y, Chen J, Wang L, Hu H, Liu H, Zheng H, Xia J, Chen J, Li C, Li X, Tang H, Liu J, Ren R, Hu Y, Li Z.
He D, et al.
Proc Natl Acad Sci U S A. 2025 Jul;122(26):e2422267122. doi: 10.1073/pnas.2422267122. Epub 2025 Jun 25.
Proc Natl Acad Sci U S A. 2025.
PMID: 40560608